Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Go back to Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test| (NASDAQ: CODX) | Delayed: 0.99 -0.02 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.99 | EPS | $ | |||
| Volume | 10,077 | |||||
